Methylphenidate on Intracortical Inhibition in Methamphetamine Abusers Attention Deficit Hyperactivity Disorder (ADHD)
NCT01651169 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2014-11-18
Summary
Previous studies using transcranial magnetic stimulation (TMS) with paired pulse protocols have shown that a conditioning TMS pulse applied to the human motor cortex changes the excitability of motor pathways from the motor cortex to spinal motorneurons. These effects depended on the stimulus intensity of both conditioning and test pulse and also the ISI). A characteristical sequence of inhibition (short interval cortical inhibition \[SICI\], GABA-Aerg), facilitation (intracortical facilitation \[ICF\]), and inhibition again (long interval cortical inhibition \[LICI\], GABA-Berg) is thought to be physiologically involved in motor control. Previous studies have also shown that neuronal inhibitory motor circuits are also disturbed in ADHD which will be restored by using methylphenidate. In this study the investigators sought to investigate if methamphetamine abuse (from the same chemical class of medications) will alter such effects of methylphenidate.
Conditions
- Attention Deficit Hyperactivity Disorder
Interventions
- OTHER
-
methylphenidate tablets and Inter-stimulus Intervals (ISI)
We administer 2 single doses of methylphenidate tablets (10mg) separated by a week interval. A paired pulse protocols will be performed with ten single (unconditioned test pulse) and ten paired TMS pulses (conditioning and test pulse) in an intermixed randomized order. Short interval cortical inhibition is measured with an Inter-stimulus Intervals (ISI) of 3 msec and a stimulator output of 80% RMT for the conditioning stimulus and 1mVT stimulation intensity for the test stimulus. ICF investigation is measured with an ISI of 13 msec), with the condition of an ISI of 50 msec (ISI 50) and both stimuli applied with 1mVT intensity). Long Interval Cortical Inhibition (LICI) is measured with ISIs of 100 msec (ISI 100), 200 msec (ISI 200), and 300 msec (ISI 300); both stimuli with 1mVT intensity
- OTHER
-
methylphenidate tablets and Inter-stimulus Intervals (ISI)
We administer 2 single doses of methylphenidate tablets (10mg) separated by a week interval. A paired pulse protocols will be performed with ten single (unconditioned test pulse) and ten paired TMS pulses (conditioning and test pulse) in an intermixed randomized order. Short interval cortical inhibition is measured with an Inter-stimulus Intervals (ISI) of 3 msec and a stimulator output of 80% RMT for the conditioning stimulus and 1mVT stimulation intensity for the test stimulus. ICF investigation is measured with an ISI of 13 msec), with the condition of an ISI of 50 msec (ISI 50) and both stimuli applied with 1mVT intensity). Long Interval Cortical Inhibition (LICI) is measured with ISIs of 100 msec (ISI 100), 200 msec (ISI 200), and 300 msec (ISI 300); both stimuli with 1mVT intensity.
Sponsors & Collaborators
-
Tehran University of Medical Sciences
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2015-11-30
- Completion
- 2016-03-31
Countries
- Iran
More Related Trials
-
Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder
NCT02951754 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
NCT00501293 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Stimulants and In-Scanner Motion on Attentive Task Performance in ADHD (ADHD_NFB)
NCT06779825 ·Status: NOT_YET_RECRUITING
-
Effect of Methylphenidate on Connectivity
NCT01764672 ·Status: WITHDRAWN ·Phase: PHASE4
-
Stimulant Effects on Brain Activity
NCT02453698 ·Status: COMPLETED ·Phase: PHASE1
-
Transcranial Magnetic Stimulation in Treatment of Attention Deficit/Hyperactivity Disorders
NCT01618110 ·Status: UNKNOWN ·Phase: NA
-
Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy
NCT00151983 ·Status: COMPLETED ·Phase: PHASE3
-
rTMS in Children and Adolescents With ADHD:
NCT06389864 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders
NCT00025779 ·Status: COMPLETED ·Phase: NA
-
Enhancing ADHD Driving Performance With Stimulant Medication
NCT00572026 ·Status: UNKNOWN ·Phase: NA
-
Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder
NCT04532190 ·Status: RECRUITING ·Phase: NA
-
Role of Transcranial Direct Current Stimulation (tDCS) in Patients With Attention Deficit Hyperactivity Disorder (ADHD)
NCT02580890 ·Status: COMPLETED ·Phase: NA
-
Impact of Attention Deficit/Hyperactivity Disorder and Substance Use Disorder on Motorcycle Traffic Accidents
NCT00536419 ·Status: UNKNOWN ·Phase: PHASE4
-
Motivation and Methylphenidate
NCT03190681 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Carnitine as an Adjunct to Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder
NCT01099072 ·Status: UNKNOWN ·Phase: PHASE2
-
Transcutaneous Electrical Acupoint Stimulation for the Treatment of ADHD
NCT03917953 ·Status: COMPLETED ·Phase: NA
-
TM Meditation in Children With ADD/ADHD
NCT03817593 ·Status: WITHDRAWN
-
Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children
NCT00183391 ·Status: COMPLETED ·Phase: PHASE4
-
Methylphenidate for Treating Children With ADHD and Tourette Syndrome
NCT00441649 ·Status: COMPLETED ·Phase: NA
-
Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach
NCT01678209 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
NCT00499863 ·Status: COMPLETED ·Phase: PHASE3
-
Further Studies of Attention Deficit Disorder - Residual Type (RT)
NCT00693212 ·Status: COMPLETED ·Phase: PHASE3
-
Inhibition Control of Children and Adolescents With ADHD
NCT01677819 ·Status: COMPLETED
-
Sleep and Nocturnal Melatonin in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
NCT01329510 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)
NCT00428792 ·Status: COMPLETED ·Phase: PHASE3